- CareValidate Launches Expanded HRT Offering
by Marissa Plescia on October 25, 2026 at 11:22 pmCareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on MedCity News.
- Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science
by Frank Vinluan on October 25, 2026 at 4:13 pmLycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair. The post Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science appeared first on MedCity News.
- Congress’s Patient Matching Fix Won’t Work — Here’s What Would
by Nidhi Singh on October 25, 2026 at 1:34 pmThe MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution. The post Congress’s Patient Matching Fix Won’t Work — Here’s What Would appeared first on MedCity News.
- Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR
by Elijah Fernandez on October 25, 2026 at 1:21 pmIn most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not. The post Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR appeared first on MedCity News.
- Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow
by Jenna Congdon on October 25, 2026 at 12:30 pmFractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive findings, the stock’s sharp decline highlighted a contrast between the clinical findings and the market’s response. The post Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow appeared first on MedCity News.
